Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

As part of the new Pharma Leaders Today series, Peter Pitts, President and co-founder of the Center for Medicine in the Public Interest and Partner/Director Global Healthcare, Porter Novelli, spoke to Andrea Charles from Pharma IQ, about the personalised medicine and the

Corrado Priami, CEO and President of CoSBi (Centre for Computational and Systems Biology), joins Helen Winsor from Pharma IQ, to talk about how we can ensure the delivery of safer and more efficacious drugs to market with algorithmic systems and in-silico technologies. Priami discusses

Enhancing laboratory innovation and automation can minimise compliance risk and improve workflow from lab bench to product release. In this exclusive Pharma IQ panel discussion, in conjunction with the 2011 Smart Lab Exchange, John Helfrich, Vice President, GMP Automation

Corrado Priami, CEO and President of CoSBi (Centre for Computational and Systems Biology), joins Helen Winsor from Pharma IQ, to talk about how we can ensure the delivery of safer and more efficacious drugs to market with algorithmic systems and in-silico technologies. Priami discusses

Qualification of equipment and validation of analytical methods are critical components for the implementation of process analytical technology (PAT). Martin Warman, Scientific Fellow, Analytical Development at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discuss the

Qualification of equipment and validation of analytical methods are critical components for the implementation of process analytical technology (PAT). Martin Warman, Scientific Fellow, Analytical Development at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discuss the

Mickel Hedemand, Internal Advisor, Licensing Division at the Danish Medicines Agency, spoke to Andrea Charles from Pharma IQ, about the commonest reasons why companies fail first time submission and the challenges of developing globally effective submission

Toxicology formulation is an essential component of drug development. Dr. Chong-Hui Gu, Associate Director at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discusss how novel formulation technologies can solve the exposure limit of poorly soluble

Toxicology formulation is an essential component of drug development. Dr. Chong-Hui Gu, Associate Director at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discusss how novel formulation technologies can solve the exposure limit of poorly soluble

Tim Chesworth, Team Manager - Packaging & Devices at  AstraZeneca, joins Andrea Charles from Pharma IQ, to speak about delivering patient compliance through user focused development of delivery systems. Chesworth discusses the key drivers of the pre-filled syringes and

Oncology is the largest investment area for the pharmaceutical industry, as a result there is a great deal of competition between key players and emphasis on speeding time to market. Benedikte Thunes Akre, Scientific Advisor - Oncology at Bristol Myers-Squibb, spoke to Andrea

Dirk Schaub, IP Crime Investigator at Germany Customs, joins Helen Winsor from Pharma IQ, to discuss challenges and recent developments in anti-counterfeiting. He highlights the main threats facing the industry at the moment, his ideas on preventative action that can be taken and ways

Dr. Frank Binder, Director, International Logistics & Supply Chain at Celgene, joins Andrea Charles from Pharma IQ, to discuss the key considerations for selecting business models across Asia and how to choose the right partners for local distribution. Binder also shares his top

Mads Ropke, Senior Scientist at LEO Pharma, joins Helen Winsor from Pharma IQ to discuss companion diagnostics and how we can ensure the delivery of safer and more efficacious drugs to market. First, he outlines how companion diagnostics can help us to administer the right drug at the

Alastair Scarlett, Regulatory Operations Project Manager at UCB Pharma, joins Helen Winsor from Pharma IQ to discuss developments in regulatory information management (RIM). In this exclusive interview, Scarlett takes a look at key innovations in the pipeline in RIM. Next he looks at